BioCryst Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BCRX Nasdaq 2830 www.biocryst.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals Inc (BCRX) (Q3 2026) Earnings Call Highlights: ORLADEYO Revenue Climbs ... - Nov 5th, 2026 2:07 am
BioCryst to Present at Upcoming Investor Conferences - Nov 4th, 2026 2:01 pm
BioCryst Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary - Nov 4th, 2026 11:01 am
BioCryst (BCRX) Q3 2026 Earnings Call Transcript - Nov 4th, 2026 10:30 am
BioCryst Pharmaceuticals Q3 Earnings Call Highlights - Nov 4th, 2026 9:14 am
BioCryst Pharmaceuticals (BCRX) Surpasses Q3 Earnings and Revenue Estimates - Nov 4th, 2026 5:55 am
BioCryst: Q3 Earnings Snapshot - Nov 4th, 2026 5:22 am
BioCryst Reports Third Quarter 2026 Financial Results - Nov 4th, 2026 5:00 am
Bioventus (BVS) Matches Q3 Earnings Estimates - Nov 2nd, 2026 2:55 pm
How New HAE Data At BioCryst Pharmaceuticals Stock Has Changed Its Investment Story - Oct 30th, 2026 9:18 pm
Wall Street Analysts See a 137.91% Upside in BioCryst (BCRX): Can the Stock Really Move This High? - Oct 30th, 2026 6:55 am
Pacira BioSciences (PCRX) Reports Next Week: Wall Street Expects Earnings Growth - Oct 29th, 2026 7:00 am
Is AxoGen (AXGN) Outperforming Other Medical Stocks This Year? - Oct 29th, 2026 6:40 am
BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting - Oct 29th, 2026 5:00 am
BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Oct 28th, 2026 7:00 am
BioCryst to Report Third Quarter 2026 Financial Results on November 4 - Oct 21st, 2026 2:01 pm
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE - Oct 21st, 2026 5:00 am
BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble? - Oct 15th, 2026 12:05 pm
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth - Oct 5th, 2026 5:00 am
Claude AI Just Bought These 2 Pharma Stocks - Sep 29th, 2026 7:26 am